Lipocine Inc. 8-K Filing

From the Filing

EDGAR Filing Documents for 0001493152-26-014835 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001493152-26-014835 Filing Date 2026-04-02 Accepted 2026-04-02 09:40:13 Documents 60 Period of Report 2026-04-02 Items Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K form8-k.htm iXBRL 8-K 40072 2 EX-99.1 ex99-1.htm EX-99.1 36932 3 GRAPHIC form8-k_001.jpg GRAPHIC 3050 4 GRAPHIC ex99-1_001.jpg GRAPHIC 80056 5 GRAPHIC ex99-1_002.jpg GRAPHIC 210206 6 GRAPHIC ex99-1_003.jpg GRAPHIC 162715 7 GRAPHIC ex99-1_004.jpg GRAPHIC 137902 8 GRAPHIC ex99-1_005.jpg GRAPHIC 83123 9 GRAPHIC ex99-1_006.jpg GRAPHIC 177061 10 GRAPHIC ex99-1_007.jpg GRAPHIC 193534 11 GRAPHIC ex99-1_008.jpg GRAPHIC 106679 12 GRAPHIC ex99-1_009.jpg GRAPHIC 183240 13 GRAPHIC ex99-1_010.jpg GRAPHIC 127137 14 GRAPHIC ex99-1_011.jpg GRAPHIC 130983 15 GRAPHIC ex99-1_012.jpg GRAPHIC 121174 16 GRAPHIC ex99-1_013.jpg GRAPHIC 86064 17 GRAPHIC ex99-1_014.jpg GRAPHIC 148301 18 GRAPHIC ex99-1_015.jpg GRAPHIC 134296 19 GRAPHIC ex99-1_016.jpg GRAPHIC 83010 20 GRAPHIC ex99-1_017.jpg GRAPHIC 139457 21 GRAPHIC ex99-1_018.jpg GRAPHIC 146975 22 GRAPHIC ex99-1_019.jpg GRAPHIC 155805 23 GRAPHIC ex99-1_020.jpg GRAPHIC 77615 24 GRAPHIC ex99-1_021.jpg GRAPHIC 158457 25 GRAPHIC ex99-1_022.jpg GRAPHIC 182243 26 GRAPHIC ex99-1_023.jpg GRAPHIC 178244 27 GRAPHIC ex99-1_024.jpg GRAPHIC 120050 28 GRAPHIC ex99-1_025.jpg GRAPHIC 73414 29 GRAPHIC ex99-1_026.jpg GRAPHIC 137840 30 GRAPHIC ex99-1_027.jpg GRAPHIC 182732 31 GRAPHIC ex99-1_028.jpg GRAPHIC 70293 32 GRAPHIC ex99-1_029.jpg GRAPHIC 152378 33 GRAPHIC ex99-1_030.jpg GRAPHIC 156531 34 GRAPHIC ex99-1_031.jpg GRAPHIC 156825 35 GRAPHIC ex99-1_032.jpg GRAPHIC 34051 36 GRAPHIC ex99-1_033.jpg GRAPHIC 73446 37 GRAPHIC ex99-1_034.jpg GRAPHIC 164931 38 GRAPHIC ex99-1_035.jpg GRAPHIC 84998 39 GRAPHIC ex99-1_036.jpg GRAPHIC 161509 40 GRAPHIC ex99-1_037.jpg GRAPHIC 104356 41 GRAPHIC ex99-1_038.jpg GRAPHIC 111653 42 GRAPHIC ex99-1_039.jpg GRAPHIC 126213 43 GRAPHIC ex99-1_040.jpg GRAPHIC 73992 44 GRAPHIC ex99-1_041.jpg GRAPHIC 137419 45 GRAPHIC ex99-1_042.jpg GRAPHIC 137151 46 GRAPHIC ex99-1_043.jpg GRAPHIC 180669 47 GRAPHIC ex99-1_044.jpg GRAPHIC 110090 48 GRAPHIC ex99-1_045.jpg GRAPHIC 121315 49 GRAPHIC ex99-1_046.jpg GRAPHIC 72416 50 GRAPHIC ex99-1_047.jpg GRAPHIC 101529 Complete submission text file 0001493152-26-014835.txt 8587465 Data Files Seq Description Document Type Size 51 XBRL SCHEMA FILE lpcn-20260402.xsd EX-101.SCH 3014 52 XBRL LABEL FILE lpcn-20260402_lab.xml EX-101.LAB 34239 53 XBRL PRESENTATION FILE lpcn-20260402_pre.xml EX-101.PRE 22358 65 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3213 Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383 Lipocine Inc. (Filer) CIK : 0001535955 (see all company filings) EIN. : 990370688 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 26831045 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)